Yahoo Finance

Top 6 Vendors in the Global Myasthenia Gravis Drugs Market from 2017 to 2021: Technavio
Yahoo Finance
According to the research analysis, the global myasthenia gravis drugs market is characterized by key companies such as Flamel Technologies, Pfizer, Shire, F. Hoffmann-La Roche, Valeant Pharmaceuticals, and Grifols. However, these companies face stiff ...

and more »


Neurology Advisor

Alexion Seeking New Indication for Myasthenia Gravis Drug
Neurology Advisor
Alexion has submitted a marketing application to the US Food and Drug Administration (FDA) to extend the indication for Soliris (eculizumab) to be a treatment for patients with refractory generalized myasthenia gravis (gMG) who are anti-acetylcholine ...



Janesville Gazette

New group supports people with myasthenia gravis
Janesville Gazette
Joseph Ryder of Milto, was diagnosed with myasthenia gravis in 2007 after one of his eyelids began to droop. Ryder has tried since 2009 to form a support group for the disease, a chronic autoimmune neuromuscular disorder that causes weakness in the ...



Hartford Business

Alexion Seeks FDA Approval of Soliris for Refractory Myasthenia Gravis
Rare Disease Report
Myasthenia gravis often starts out as weakness in the ocular muscles but at the disease progresses to more generalized form, it can weaken head, neck, trunk, limb and respiratory muscles. Myasthenia gravis is an autoimmune disease in which antibodies ...
Soliris Application Seeks Ultra-Rare Neuromuscular Disease IndicationMonthly Prescribing Reference (registration)
Alexion Submits U.S. and EU Applications Seeking Approval of Soliris® (Eculizumab) as a Treatment for Patients with ...Business Wire (press release)
Alexion seeks to market drug for neuromuscular diseaseHartford Business
Seeking Alpha
all 5 news articles »


WalesOnline

This loving 12-year-old boy died after suffering an extremely rare ...
WalesOnline
Matthew Knowles had been diagnosed with Myasthenia Gravis - a rare autoimmune condition - a year before his death.

and more »


argenx launches Phase II proof-of-concept study of ARGX-113 for ...
P&T Community
Topline data from the study expected in second half of 2018 - 9 January 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext Brussels: ARGX), ...

and more »


LubbockOnline.com

Acupuncture heals pain and ailments | Lubbock Online | Lubbock ...
LubbockOnline.com
Acupuncture is becoming increasingly popular as a viable way to treat chronic disease and pain. It's an ancient method to treat the ill, created thousands of years ...

and more »



Santa Fe New Mexican

From optimism to a search for peace, New Mexicans react to Inauguration Day
Santa Fe New Mexican
Northcutt — who suffers from myasthenia gravis, a condition that weakens the muscles — prayed especially hard, she said, as she walked the curves of the labyrinth, where she said balance can be found. Afterward, she felt immense gratitude, fueling ...



argenx launches Phase II proof-of-concept study of ARGX-113 for the treatment of myasthenia gravis
GlobeNewswire (press release)
Breda, the Netherlands / Ghent, Belgium - argenx (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, ...


Google News